Prilenia filed a European Marketing Authorization Application (MAA) with the EMA. What's next for the United States? katrina4384Sep 3, 20241 min readTo learn more about this news and Pridopidine, please read our press release here: Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review | Prilenia Therapeutics B.V.
To learn more about this news and Pridopidine, please read our press release here: Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review | Prilenia Therapeutics B.V.
Comentários